BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30
• 31

• 

  Rare diseases

  Intellia’s CRISPR Gene Editor Cuts Hereditary Angioedema Attacks by 81% in Phase II Study

  Jefferies analyst Maury Raycroft said in a note to investors that Thursday’s mid-stage readout pointed to the “unprecedented” complete response rate of Intellia’s investigational in vivo gene editing therapy in the disorder.

  October 25, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Vaccines

  CDC Reaffirm RSV Vaccination Guidelines, Declines Expanding Coverage to Younger Adults

  The CDC’s vaccine advisors on Thursday maintained that respiratory syncytial virus immunization is only recommended for adults aged 75 and older, and in seniors 60 to 74 years who are at risk of severe disease.

  October 25, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Earnings

  Sanofi Beats Q3 Forecasts Fueled by 381% Growth in Beyfortus Sales

  The French drugmaker’s newly launched respiratory syncytial virus antibody Beyfortus far exceeded analyst expectations, bringing in almost $700 million in the third quarter. Leerink Partners analyst David Risinger in a Friday note to investors said Sanofi expects Q4 Beyfortus sales similar to Q3.

  October 25, 2024

   · 

  3 min read

   · 

  Tristan Manalac
• Press Releases

  Dyno Therapeutics Forms New Strategic Partnership With Roche To Advance AAV Gene Therapy Vectors For Neurological Diseases

  October 25, 2024

   · 

  4 min read
• Press Releases

  Vericel to Report Third-Quarter 2024 Financial Results on November 7, 2024

  October 25, 2024

   · 

  2 min read
• Press Releases

  ARS Pharmaceuticals Showcases Intranasal Epinephrine Data at 2024 American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting

  October 25, 2024

   · 

  9 min read
• Press Releases

  Calidi Biotherapeutics to Present Data Supporting RTNova at Upcoming Scientific Conferences

  October 25, 2024

   · 

  5 min read
• Press Releases

  Ludwig Enterprises Files Provisional Patent for Revolutionary Cancer Screening Algorithm, Plans 2024 Launch as Revealia(TM)

  October 25, 2024

   · 

  2 min read
• Press Releases

  Philips and Medtronic advocacy partnership aims to help accelerate access to life-saving treatments

  October 25, 2024

   · 

  5 min read
• Press Releases

  EpiVax and CUBRC Awarded FDA Contract Worth $2M for Development of Control Peptides for Immunogenicity Risk Assessment Assays Supporting Regulatory Filings of Generic Peptide Drugs

  October 25, 2024

   · 

  3 min read